Observational studyMedicina (Kaunas, Lithuania)2026

Early SGLT2 Inhibitor Therapy in Acute Coronary Syndrome: Mitigating Adverse Remodeling in High-Risk Phenotypes-A Real-World Study.

Teodora Mateoc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.